Cargando…

Neutrophil gelatinase-associated lipocalin as a predictor of adverse renal outcomes in immunoglobulin A nephropathy

Detalles Bibliográficos
Autor principal:	Ma, Seong Kwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438284/ https://www.ncbi.nlm.nih.gov/pubmed/25995660 http://dx.doi.org/10.3904/kjim.2015.30.3.305

Ejemplares similares

Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy
por: Park, Ga-Young, et al.
Publicado: (2015)

The role of neutrophil-gelatinase-associated lipocalin in early diagnosis of contrast nephropathy
por: Khatami, M. R., et al.
Publicado: (2015)

Neutrophil Gelatinase-associated Lipocalin: As a Predictor of Early Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Kaul, A., et al.
Publicado: (2018)

Neutrophil gelatinase–associated lipocalin as a biomarker of nephropathy in sickle cell disease
por: Marouf, Rajaa, et al.
Publicado: (2021)

New Issues With Neutrophil Gelatinase-associated Lipocalin in Acute Kidney Injury
por: Cho, Sun Young, et al.
Publicado: (2023)

Role of neutrophil gelatinase-associated lipocalin in renal cell carcinoma
por: Che, Kai, et al.
Publicado: (2021)

High serum and urine neutrophil gelatinaseassociated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy
por: Rhee, Harin, et al.
Publicado: (2015)

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Nephropathy
por: Kim, So Young, et al.
Publicado: (2018)

Diagnostic value of neutrophil gelatinase-associated lipocalin in diabetic nephropathy: a meta-analysis
por: Chen, Bin, et al.
Publicado: (2019)

Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans
por: Liu, Zhenjie, et al.
Publicado: (2020)

Evaluation of Neutrophil Gelatinase-associated Lipocalin and Cystatin C as Early Markers of Diabetic Nephropathy
por: Siddiqi, Zeba, et al.
Publicado: (2017)

Neutrophil gelatinase-associated lipocalin as an early indicator for postoperative renal failure
por: Marel, CD Van der, et al.
Publicado: (2010)

Neutrophil Gelatinase–Associated Lipocalin in Dogs with Naturally Occurring Renal Diseases
por: Hsu, W.‐L., et al.
Publicado: (2014)

Plasma neutrophil gelatinase-associated lipocalin and kidney graft outcome
por: Kremer, Daan, et al.
Publicado: (2021)

Urinay neutrophil gelatinase-associated lipocalin as a biomarker in different renal problems
por: TURGUT, Didem, et al.
Publicado: (2020)

Clinical Significance of the Interval Change of Plasma Neutrophil Gelatinase-Associated Lipocalin in Acute Kidney Injury and Acute Kidney Injury Superimposed on Chronic Kidney Disease
por: Kim, Ha Yeon, et al.
Publicado: (2019)

Neutrophil Gelatinase-Associated Lipocalin as a Promising Novel Biomarker for Early Detection of Kidney Injury
por: Cho, Sun Young, et al.
Publicado: (2018)

Interleukin 18 and neutrophil-gelatinase associated lipocalin in assessment of the risk of contrast-induced nephropathy in children
por: Lichosik, Marianna, et al.
Publicado: (2016)

Association of peripheral blood neutrophil gelatinase‐associated lipocalin levels with bone marrow neutrophil gelatinase‐associated lipocalin levels and neutrophil count in hematologic malignancy
por: Cho, Chi‐Hyun, et al.
Publicado: (2019)

Neutrophil Gelatinase-Associated Lipocalin as an Early Predictor of Contrast-Induced Nephropathy Following Endovascular Aortic Repair for Abdominal Aortic Aneurysm
por: Li, Lubin, et al.
Publicado: (2021)

Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane!
por: Honore, Patrick M., et al.
Publicado: (2016)

Neutrophil Gelatinase-Associated Lipocalin Levels During Pneumoperitoneum
por: Kiseli, Mine, et al.
Publicado: (2017)

Neutrophil gelatinase–associated lipocalin as an immunomodulator in endocrine hypertension
por: Araos, Patricio, et al.
Publicado: (2022)

Hepcidin and Neutrophil Gelatinase-Associated Lipocalin as a Biomarker for Acute Kidney Injury Linked Iron Metabolism
por: Cho, Sun Young, et al.
Publicado: (2020)

Predictive value of cystatin C and neutrophil gelatinase-associated lipocalin in contrast-induced nephropathy: A meta-analysis
por: He, Yi, et al.
Publicado: (2020)

Importance of Neutrophil Gelatinase-Associated Lipocalin in Differential Diagnosis of Acute and Chronic Renal Failure
por: Ozkan, Seda, et al.
Publicado: (2014)

Diagnostic value of neutrophil gelatinase-associated lipocalin for renal injury in asphyxiated preterm infants
por: Song, Yu'E, et al.
Publicado: (2017)

Neutrophil gelatinase-associated lipocalin in ICU patients developing oliguria
por: Roman, A, et al.
Publicado: (2011)

Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer
por: Candido, Saverio, et al.
Publicado: (2014)

Urinary Excretion of Neutrophil Gelatinase-Associated Lipocalin in Diabetic Rats
por: Arellano-Buendía, Abraham Said, et al.
Publicado: (2014)

The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery
por: Passov, Arie, et al.
Publicado: (2019)

The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL)
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Urinary neutrophil gelatinase-associated lipocalin is an early predictor of acute kidney injury in premature infants
por: Kuribayashi, Ryota, et al.
Publicado: (2016)

Urinary neutrophil gelatinase-associated lipocalin is an excellent predictor of mortality in intensive care unit patients
por: Algethamy, Haifa M., et al.
Publicado: (2017)

Expression of neutrophil gelatinase-associated lipocalin in low osmolar contrast-induced nephropathy in rats and the effect of N-acetylcysteine
por: Li, Wen-Hua, et al.
Publicado: (2016)

Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study)
por: Ribitsch, Werner, et al.
Publicado: (2017)

Neutrophil gelatinase-associated lipocalin in dehydrated patients: a preliminary report
por: Antonopoulos, Constantine N, et al.
Publicado: (2011)

3: A REVIEW OF NGAL BIOMARKER OR NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN
por: Bahramzadeh, Behzad
Publicado: (2017)

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Cardiovascular Events in Patients with Chronic Kidney Disease
por: Hasegawa, Midori, et al.
Publicado: (2016)

Urine Neutrophil Gelatinase-associated Lipocalin (NGAL) for Prediction of Persistent AKI and Major Adverse Kidney Events
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cvjhf0dgkvfkjk0ln61fdk8u43